1、基因编辑板块有哪些标的值得关注?
2、$Autolus Therapeutics(AUTL)AML数据不错,触发黑石的7500万美元投资,是否有配置机会?
3、$理想汽车(LI)$ 、$爱奇艺(IQ)$ 等期权异动,后续走势如何看?
$恒瑞医药(SH600276)$查看全文
产业链观察2022-04-25 19:29
药闻▶2022年4月25日,开发下一代程序化T细胞疗法的临床阶段生物制药公司$Autolus Therapeutics(AUTL)$ 今天宣布,美国食品和药物管理局(FDA)已授予其主要基因疗法obecabatagene autoleucel (obecel)再生医学高级疗法(RMAT)称号。
这是一种CD19导向的自体嵌合抗原受体(CAR)T疗...查看全文
美股滚雪球2021-12-31 11:46
瑞穗明年看好的医药股:$Autolus Therapeutics(AUTL)$ $Fate Therapeutics(FATE)$ $Leap Therapeutics(LPTX)$ 和$Arcus Biosciences(RCUS)查看全文
产业链观察2021-11-08 16:07
药闻▶黑石正投资$Autolus Therapeutics(AUTL)$ 2.5 亿美元,押注其针对严重白血病的细胞疗法治疗,该疗法可用于其他形式的癌症。查看全文
Autolus Therapeutics(AUTL)01-24 06:12
$Autolus Therapeutics(AUTL)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001730463-23-000007 Act: 34 Size: 278 KB 网页链接查看全文
Autolus Therapeutics(AUTL)2022-12-20 05:18
$Autolus Therapeutics(AUTL)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001172661-22-002614 Act: 34 Size: 103 KB 网页链接查看全文
Autolus Therapeutics(AUTL)2022-12-22 06:27
$Autolus Therapeutics(AUTL)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-22-310163 Act: 34 Size: 22 KB 网页链接查看全文
Autolus Therapeutics(AUTL)2022-12-12 19:06
$Autolus Therapeutics(AUTL)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-22-301911 Act: 34 Size: 296 KB 网页链接查看全文
Autolus Therapeutics(AUTL)2019-04-09 08:40
$Autolus Therapeutics(AUTL)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-04-08 AccNo: 0001193125-19-100854 Size: 40 KB 网页链接查看全文
Autolus Therapeutics(AUTL)2019-04-09 08:40
$Autolus Therapeutics(AUTL)$ F-1 - Registration statement for certain foreign private issuers Filed: 2019-04-08 AccNo: 0001193125-19-100758 Size: 1 MB 网页链接查看全文
Autolus Therapeutics(AUTL)2019-04-06 08:40
$Autolus Therapeutics(AUTL)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-04-05 AccNo: 0001193125-19-099275 Size: 14 KB 网页链接查看全文
Autolus Therapeutics(AUTL)2019-04-02 20:55
$Autolus Therapeutics(AUTL)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-04-02 AccNo: 0001193125-19-095146 Size: 3 MB 网页链接查看全文
用户48783635432019-04-01 15:10
【汇众医疗】几家生物技术公司癌症药物研发有所突破,股价上涨
$Autolus Therapeutics(AUTL)$ $Constellation Pharmaceuticals(CNST)$ 美国癌症研究协会数据显示,生物技术公司Advaxis、AUTL、CNST、DVAX、JNCE、NTGN和TROV在各自主打的癌症治疗药物研发方面均有所突破,股价上涨,发展态势良...查看全文
Autolus Therapeutics(AUTL)2019-03-28 08:35
$Autolus Therapeutics(AUTL)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-03-27 AccNo: 0001193125-19-088447 Size: 40 KB 网页链接查看全文
Autolus Therapeutics(AUTL)2019-03-16 08:40
$Autolus Therapeutics(AUTL)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-03-15 AccNo: 0001193125-19-076928 Size: 2 MB 网页链接查看全文
Autolus Therapeutics(AUTL)2019-02-26 08:40
$Autolus Therapeutics(AUTL)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-02-25 AccNo: 0001193125-19-049964 Size: 104 KB 网页链接查看全文
Autolus Therapeutics(AUTL)2019-02-26 08:40
$Autolus Therapeutics(AUTL)$ 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Filed: 2019-02-25 AccNo: 0001730463-19-000004 Size: 6 MB 网页链接查看全文
Autolus Therapeutics(AUTL)2019-02-15 08:46
$Autolus Therapeutics(AUTL)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-14 AccNo: 0001193125-19-039614 Size: 106 KB 网页链接查看全文
智通财经APP获悉,11月8日(周一)美股盘前,截至北京时间17:23,Autolus Therapeutics(AUTL.US)涨36.15%,报7.57美元。消息面上,美国私募股权巨头黑石集团宣布,将向英国生物技术公司Autolus Therapeutics注资至多2.5亿美元,以资助一种... 网页链接
智通财经APP获悉,2021年6月11日,生物制药公司Autolus Therapeutics plc(AUTL.US)在2021年欧洲血液学协会(EHA)网络大会上发表了关于AUTO1(一种CAR-T疗法obecabtagene autoleucel,obe-cel)疗法治疗惰性B细胞淋巴瘤(IBCL)中的报告。 ... 网页链接
$Autolus Therapeutics(AUTL)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001730463-23-000007 Act: 34 Size: 278 KB 网页链接
$Autolus Therapeutics(AUTL)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-22-310163 Act: 34 Size: 22 KB 网页链接
$Autolus Therapeutics(AUTL)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001172661-22-002614 Act: 34 Size: 103 KB 网页链接
$Autolus Therapeutics(AUTL)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001387131-22-012374 Act: 34 Size: 100 KB 网页链接
$Autolus Therapeutics(AUTL)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-22-303864 Act: 34 Size: 157 KB 网页链接
$Autolus Therapeutics(AUTL)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-22-301909 Act: 33 Size: 1 MB 网页链接
$Autolus Therapeutics(AUTL)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-22-301911 Act: 34 Size: 296 KB 网页链接
$Autolus Therapeutics(AUTL)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-22-301047 Act: 34 Size: 95 KB 网页链接
$Autolus Therapeutics(AUTL)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-22-301031 Act: 33 Size: 1 MB 网页链接
$Autolus Therapeutics(AUTL)$ 6-K/A [Amend] Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001730463-22-000037 Act: 34 Size: 221 KB 网页链接